We're bringing the Jafron F20 Double Plasma Molecular Adsorption System (DPMAS) to the UK market, extending a technology already trusted by clinicians across multiple countries worldwide.
Designed to support patients with acute and acute-on-chronic liver failure through extracorporeal blood purification, the F20 is currently progressing through UK regulatory registration ahead of a phased rollout, beginning with select UK hospital partners.
Register your interest below to be among the first to hear when the F20 becomes available in the UK.

Follow us on LinkedIn.
For more information please reach out to webrequests@airsentry.co.uk

